The National Edible Fungus Processing Technology R&D Center of Henan University has made progress in the research of Poria
By: Date: 2021-04-06 Categories: foodtechnology Tags: ,
  The National Edible Fungus Processing Technology Research and Development Center of Henan University has made new progress in the research of Poria cocos, and reviewed the research progress of Poria cocos chemical components and biological activities in recent years. The result was published in the Journal of Chemistry with the title”Phytochemistry and Biological Activities of Poria” (immediate IF1.926, District 4 of the Chinese Academy of Sciences).
   Poria is the dried sclerotia of the Basidiomycota, Agaricomycetes, Polyporaceae fungus Poria cocos (Schw.) Wolf. Its main producing areas are Anhui, Yunnan and Hubei. Poria has a long history and was first published in”Shen Nong’s Materia Medica”. In the Qin and Han dynasties, people believed that Poria had the effect of prolonging life and longevity, and it was often used as a tea drink.
   So far, the main chemical constituents found in Poria are triterpenes, polysaccharides, sterols, fatty acids, volatile oils, etc. Pharmacological studies have shown that most of the biologically active compounds are triterpenes and polysaccharides. Poria has anti-tumor, immune regulation, liver protection, hypoglycemic, anti-oxidation, anti-inflammatory and intestinal regulation effects. Poria is also used to treat uterine fibroids, chronic pelvic inflammatory disease, endometriosis, ovarian cysts, early pregnancy miscarriage, menstrual abdominal pain, medical abortion, colds, headaches, colitis, arthritis, urinary tract infections, nephritis and Some tumor diseases, such as esophageal cancer and ovarian cancer.
The National Edible Fungus Processing Technology R&D Center of Henan University has made progress in the research of Poriaimage
  Fu Ling’s chemical composition (excerpt)
   Literature review found that Poria has played a vital role in human health and has the potential to be developed as anti-tumor, immunomodulatory and anti-inflammatory drugs.